A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $20.9 | $237.5 | 10% |
|
| Shares Out (Mil) | 2.8 | 53.9 | 10% |
|
| Institutional Ownership | 88.3% | 93.1% | 56% |
|
| Float (Mil) | 4.6 | 41.4 | 11% |
|
| Beta | 1.73 | 0.95 | 87% |
|
| Avg Daily Volume (000s) | 54 | 628 | 30% |
|
| Price Change (52-week) |
(46.6%) | 49.0% | 21% |
|
| Growth | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 12.4% | na |
|
| Net Income (5yr) | (49.7%) | (10.2%) | 7% |
|
| EPS (5yr) | na | 15.7% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.7%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($1.760) | ($7.170) | ($3.185) | |
| Month Ago EPS | ($1.760) | ($7.170) | ($3.185) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($1.685) | ($6.880) | ($2.910) | |
| Year/Year Chg | (7.2%) | (51.5%) | (94.0%) | |
| Financials | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($19) | ($44) | 24% |
|
| EPS (TTM) | ($8.521) | ($1.600) | 5% |
|
| Operating Cash Flow (TTM) (Mil) | ($15) | ($33) | 17% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $2 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $4 | 18% |
|
| Enterprise Value (Q1) (Mil) | $24 | $174 | 12% |
|
| Valuation | QNRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.22 | 2.27 | 57% |
|
| P/E | na | 19.7 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (75.3%) | na |
|
| ROA | (178.8%) | (47.7%) | 2% |
|
| ROE | (575.7%) | (55.0%) | 1% |
|
| Liabilities to Assets | 67.1% | 29.4% | 63% |
|
| F-Score | 1 | 2 | 1% |
|
Quoin Pharmaceuticals, Ltd. did not pass any screens on 10/12/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
